On January 17, the Drug Enforcement Administration (DEA) and the U.S. Department of Health and Human Services (HHS) jointly published two final ...

More New Yorkers received scripts for buprenorphine, a med used to treat opioid addiction, amid fight against record-high ...

The New York State health department is underscoring the importance of addiction medication in ending the opioid crisis.

An online-based mindfulness treatment program significantly reduced opioid craving among participants with opioid use ...

Wright State University clinical psychologist Jeremiah Schumm, Ph.D., will train dozens of local clinicians in an innovative behavioral couple therapy to help people with substance use disorders.

Opioid-related neurocognitive symptoms among patients on long-term opioid therapy were most prevalent during the course of therapy.

Tonix is Preparing for Potential Launch of TNX-102 SL for the management of fibromyalgia with U.S. FDA PDUFA goal date of August 15, 2025 ...

Now a third option is available after the U.S. Food and Drug Administration last week approved Vertex Pharmaceuticals’ Suzetrigine, sold as twice-daily Journavx, a non-addictive prescription drug for ...